Amarantus Bioscience Holdings Inc (AMBS)

[MUKA1]

This confirms previously published work on LymPro (Stieler et al, 2001, and Stieler et al, 2012)


This finding was confirmed in a second study conducted by Jens Steiler, et al, where the authors were able to retrospectively differentiate AD from Other Dementias [(OD), mostly Idiopathic Parkinson’s disease] with 95% sensitivity and 90% specificity [Steiler, J et al, 2012. Neurobio Aging 33:234-341]
From posterboard, http://content.stockpr.com/amarantus/files/docs/Poster+1+FINAL+FINAL.pdf